ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 217 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $681,000 | -75.6% | 14,814 | -64.8% | 0.00% | -50.0% |
| Q4 2021 | $2,794,000 | +61.8% | 42,092 | +52.2% | 0.00% | +100.0% |
| Q3 2021 | $1,727,000 | -23.8% | 27,660 | +1.1% | 0.00% | -50.0% |
| Q2 2021 | $2,265,000 | +1.1% | 27,351 | -19.1% | 0.00% | 0.0% |
| Q1 2021 | $2,241,000 | -58.1% | 33,803 | -51.5% | 0.00% | -60.0% |
| Q4 2020 | $5,352,000 | +931.2% | 69,735 | +479.1% | 0.01% | +400.0% |
| Q3 2020 | $519,000 | +6.1% | 12,043 | +6.4% | 0.00% | 0.0% |
| Q2 2020 | $489,000 | +60.3% | 11,315 | +6.9% | 0.00% | – |
| Q1 2020 | $305,000 | -93.4% | 10,584 | -85.4% | 0.00% | -100.0% |
| Q4 2019 | $4,609,000 | +251.0% | 72,659 | +56.0% | 0.00% | +300.0% |
| Q3 2019 | $1,313,000 | -70.2% | 46,589 | -71.9% | 0.00% | -75.0% |
| Q2 2019 | $4,401,000 | +14.3% | 166,089 | -20.8% | 0.00% | 0.0% |
| Q1 2019 | $3,849,000 | +52.2% | 209,745 | +3.0% | 0.00% | +33.3% |
| Q4 2018 | $2,529,000 | +48.7% | 203,613 | -55.9% | 0.00% | +200.0% |
| Q4 2017 | $1,701,000 | -13.1% | 462,105 | +2.2% | 0.00% | -50.0% |
| Q3 2017 | $1,958,000 | +11.9% | 452,120 | +89.9% | 0.00% | 0.0% |
| Q3 2016 | $1,750,000 | – | 238,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |